Sign In
Buy STE
$228.40
-2.81 (-1.22%)
At Close: Jul 31, 2026
STERIS (STE) to Report Q1 Earnings: What's in the Cards?
09:14am, Tuesday, 27'th Jul 2021
Acquisitions of Cantel Medical and Key Surgical are expected to have contributed significantly to STERIS' (STE) first-quarter revenues.
STERIS to Host a Conference Call for Fiscal 2022 First Quarter Financial Results on August 10, 2021
09:07am, Tuesday, 27'th Jul 2021
DUBLIN, IRELAND , July 27, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 first quar
Five-Year Compounded Value of Steris Holdings
12:01pm, Friday, 02'nd Jul 2021
In a world obsessed with price movements of stocks, it's easy to lose sight of what those prices represent -- the value of holding a company's future profit potential. One of the key ways that profit
Steris (STE) Up 5% Since Last Earnings Report: Can It Continue?
12:02pm, Thursday, 17'th Jun 2021
Steris (STE) reported earnings 30 days ago. What's next for the stock?
STERIS (STE) Expands Product Suite With New Acquisition
08:17am, Monday, 07'th Jun 2021
STERIS' (STE) acquisition of Cantel Medical will complement and broaden the former's product and service offerings, global reach and customers.
Here's Why You Should Add STERIS (STE) to Your Portfolio
08:16am, Tuesday, 01'st Jun 2021
Investors are optimistic about STERIS (STE) owing to strong segmental performance and huge growth potential in healthcare and pharmaceutical industries.
Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600
05:50pm, Wednesday, 26'th May 2021
NEW YORK, May 26, 2021 /PRNewswire/ -- S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: OR
STERIS plc (STE) CEO Walt Rosebrough on Q4 2021 Results - Earnings Call Transcript
01:59pm, Wednesday, 19'th May 2021
STERIS plc (STE) CEO Walt Rosebrough on Q4 2021 Results - Earnings Call Transcript
STERIS (STE) Q4 Earnings Fall Shy of Estimates, FY22 View Up
08:16am, Wednesday, 19'th May 2021
STERIS' (STE) fourth-quarter 2021 revenues improved year over year on robust growth across three segments.
Recap: Steris Q4 Earnings
04:58pm, Tuesday, 18'th May 2021
Shares of Steris (NYSE:STE) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 0.61% over the past year to $1.63, which missed the estim
STERIS Announces Financial Results for Fiscal 2021 Fourth Quarter and Full Year
04:30pm, Tuesday, 18'th May 2021
DUBLIN, IRELAND, May 18, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2021 fourth quarter ended March 31, 2021.
STERIS (STE) to Report Q4 Earnings: What's in the Cards?
09:46am, Wednesday, 12'th May 2021
STERIS (STE) is likely to have continued to gain from the robust demand of PPE and COVID-19-related products in Q4.
STERIS Announces Changes to Board of Directors
04:30pm, Tuesday, 11'th May 2021
DUBLIN, IRELAND, May 11, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced changes to its Board of Directors. David Lewis, Board member since 2010 has
STERIS (STE) Hits a New 52-Week High: What's Driving It?
09:22am, Monday, 19'th Apr 2021
Investors are optimistic about STERIS (STE) backed by elevated consumer demand and strong segmental growth in third-quarter fiscal 2021.
MedTech M&A Scaling New Heights in 2021 on Rising Investor Wealth
01:36pm, Friday, 16'th Apr 2021
While smaller tuck-in acquisitions dominated the M&A space throughout 2020, 2021 is seeing a number of colossal deals.
